Efficacy Study of Lucentis in the Treatment of Diabetic Macular Edema

Phase 2 Completed 49 enrolled Rocky Mountain Retina Consultants Genentech, Inc. · collab

RandomizedParallel-groupOpen-labelTreatment

Summary

This study will evaluate the clinical efficacy of intra-vitreal injections of Ranibizumab (Lucentis) in the treatment of Diabetic Macular Edema as compared to grid/focal laser.

Timeline

Start: 2006-07
Primary completion: 2009-02
Completion: 2009-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ranibizumab	Monoclonal antibody	0.5 mg	Intravitreal

Efficacy Study of Lucentis in the Treatment of Diabetic Macular Edema

Summary

Timeline

Drugs

Indications